General Information
Version
8.3
Revision date
2023-06-07
Product name
Riddelliine
REACH No
A
Emergency telephone
+44 (0)870 8200418
Icons in SDS
Company Information
company name
Merck Life Science UK Limited
e-mail address of the competent person responsible for the Safety Data Sheet
TechnicalService@merckgroup.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H341, H351, H361d, H372
Hazard statements
Code
Statements
H341
Suspected of causing genetic defects
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Danger Danger
Hazard statements
H341 Suspected of causing genetic defects. H351 Suspected of causing cancer. H361d Suspected of damaging the unborn child. H372 Causes damage to organs (Liver) through prolonged or repeated exposure. H341 Suspected of causing genetic defects. H351 Suspected of causing cancer. H372 Causes damage to organs through prolonged or repeated exposure. H361d Suspected of damaging the unborn child.
Precautionary statements
P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust. P264 Wash skin thoroughly after handling. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P405 Store locked up. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust. P264 Wash skin thoroughly after handling. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P405 Store locked up.
Supplemental label elements
none Reduced Labeling (<= 125 ml) none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 as amended by GB-CLP Regulation, UK SI 2019/720, and UK SI 2020/1567 Germ cell mutagenicity (Category 2), H341 Carcinogenicity (Category 2), H351 Reproductive toxicity (Category 2), H361d Specific target organ toxicity - repeated exposure (Category 1), Liver, H372 For the full text of the H-Statements mentioned in this Section, see Section 16.
